CompaniesPromore Pharma

Promore Pharma

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

148

By Phase

PHASE1/PHASE2: 1

By Status

SUSPENDED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT05603572
Hover over trial bars to see details

Recent Trials

NCT05603572Lead Sponsor
KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)
PHASE1/PHASE2Suspended
148 participants
Started: Nov 1, 2022 · Completed: Nov 30, 2027
Related Companies
Reverse Merger
acquired